A detailed history of Jfs Wealth Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 31 shares of NEO stock, worth $531. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 30 3.33%
Holding current value
$531
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$13.4 - $17.73 $13 - $17
1 Added 3.33%
31 $0
Q1 2024

Apr 30, 2024

SELL
$14.06 - $16.79 $14 - $16
-1 Reduced 3.23%
30 $0
Q4 2023

Feb 07, 2024

BUY
$11.67 - $20.73 $338 - $601
29 Added 1450.0%
31 $0
Q3 2023

Nov 02, 2023

SELL
$12.15 - $17.85 $109 - $160
-9 Reduced 81.82%
2 $0
Q2 2023

Aug 07, 2023

BUY
$14.1 - $19.83 $155 - $218
11 New
11 $0

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Jfs Wealth Advisors, LLC Portfolio

Follow Jfs Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.